Find clinical trials for Acute Myeloid Leukemia (AML) in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia

Leukemia

Myeloid Leukemia

Myelodysplastic Syndromes

Preleukemia

Syndrome

Cancer

Acute Myeloid Leukemia (AML) trials near San Antonio, TX, USA:

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)

The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...

Active, not recruiting

Acute Myeloid Leukemia (AML)

Cancer

Other: Best Supportive Care (BSC)

Drug: Venetoclax

Phase 3

AbbVie

San Antonio, Texas, United States and 164 other locations

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission (QUAZAR AML-001)

This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...

Active, not recruiting

Leukemia, Myeloid, Acute

Drug: Placebo

Drug: Oral Azacitidine

Phase 3

Celgene

San Antonio, Texas, United States and 222 other locations

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

three separate safety run-in cohorts in neuroblastoma, acute myeloid leukemia (AML), and acute lymphobla...

Active, not recruiting

Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Drug: Fludarabine

Drug: Idasanutlin

Phase 1, Phase 2

Roche

San Antonio, Texas, United States and 19 other locations

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers

This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...

Enrolling

Chronic Lymphocytic Leukemia

Acute Myeloid Leukemia

Drug: Bevacizumab (and approved biosimilars)

Drug: FOLFIRI

Phase 1

IGM Biosciences

San Antonio, Texas, United States and 57 other locations

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose), With a Food Effect Substudy at Select Study Centers

Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Astex-...

Invitation-only

Acute Myeloid Leukemia

Chronic Myelomonocytic Leukemia

Drug: ASTX727

Phase 2

Astex Pharmaceuticals

San Antonio, Texas, United States and 33 other locations

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona)

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting

Myelodysplastic Syndrome (MDS)

Drug: Azacitidine

Drug: Venetoclax

Phase 3

AbbVie

San Antonio, Texas, United States and 219 other locations

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) (PANTHER)

azacitidine. (An event is defined as death or transformation to AML in participants with MDS or CMML, whichever occurs first, and is defined...

Active, not recruiting

Leukemia, Myeloid, Acute

Leukemia, Myelomonocytic, Chronic

Drug: Pevonedistat

Drug: Azacitidine

Phase 3

Takeda

San Antonio, Texas, United States and 240 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Acute Myeloid Leukemia (AML) in .css-epvm6{white-space:nowrap;}San Antonio, TX

Related conditions:

Acute Myeloid Leukemia (AML) trials near San Antonio, TX, USA:

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission (QUAZAR AML-001)

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose), With a Food Effect Substudy at Select Study Centers

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona)

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) (PANTHER)

Find clinical trials for Acute Myeloid Leukemia (AML) in San Antonio, TX